Skip to content

Videos for Advance Care Planning in Young Adults

Videos for Advance Care Planning in Young Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04149704
Enrollment
102
Registered
2019-11-04
Start date
2019-12-13
Completion date
2022-05-05
Last updated
2025-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer

Keywords

Advanced Cancer

Brief summary

This study is a randomized trial of adolescent and young adults with advanced cancer and their caregivers to assess preferences for care in advanced cancer. This research study is examining the similarities and differences between patient's and caregiver's goals of cancer care. The names of the study interventions involved in this study may include: * Questionnaires * Video * Phone Interview

Detailed description

The research study procedures include: screening for eligibility and study interventions including questionnaires and follow up visits. \- Patients and their caregivers will be randomized into the same group; either ACP video decision aid intervention or usual care. * Patients' and caregivers' knowledge, preferences (goals of care, CPR, ventilation), and decisional conflict be assessed before and after the ACP video decision aid intervention or usual care. * Participants will be in this research study for up to 3 months with only 2 study visits. * It is expected that about 100 people (50 patients and 50 caregivers) will take part in this research study.

Interventions

BEHAVIORALACP video decision aid

10 minute video decision aid describing the goals-of-care options

OTHERUsual Care-

Verbal description of the three types of care

Sponsors

Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

All patients will be recruited from the outpatient clinics of Dana-Farber Cancer Institute (both pediatric and adult clinics),the inpatient settings of Boston Children's Hospital and Brigham and Women's Hospital, the inpatient or outpatient clinics of Massachusetts General Hospital, or virtually. Eligible study participants will give written consent to the primary investigator or study staff member before initiation of study procedures if recruited in-person. If participants are enrolled and complete study procedures virtually, they will provide verbal consent before initiating study procedures. If in-person visits cannot be conducted, eligible participants will be still be mailed a pre-notice letter that offers the chance for participants to opt-out or opt-in via email or phone call. After one week, we will call participants we have not heard from and ask if they would consider participating. Patient Eligibility criteria will include patients who are: i) Diagnosed with advanced cancer (i.e., initial first-line therapy is unsuccessful, marked by progression or relapsed disease) ii) Aged between 18-39, which is the legal age for completing an ACP document (e.g., POLST/MOLST); iii) Speak English; and iv) Have a caregiver or identified surrogate decision maker who is able to participate. v) Treated at Dana-Farber Cancer Institute or Massachusetts General Hospital

Exclusion criteria

will include: i) A diagnosis of low-grade glioma given the fact that progressive or relapsed low grade may not be clinically characterized as advanced disease and associated poor prognosis. ii) Visually impaired (note, hearing impaired is not an exclusion as the video is closed captioned); iii) Psychological state not appropriate for ACP discussions as determined by the primary oncologist; and, iv) Unable to participate in ACP discussions due to mental incapacity as determined by the Short Portable Mental Status Questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Increased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)baseline, 3 monthsAYA with advanced cancer and caregivers randomized to the video will have higher concordance in their stated goals of care between patients and caregivers at 3 month compared to baseline

Secondary

MeasureTime frameDescription
Increased Advance Care Planning (ACP) ConversationsBaseline and 3 monthsPatients randomized to the video will have more ACP conversations and documentation after 3 months.

Countries

United States

Participant flow

Recruitment details

Patient recruited while in clinic; shift to almost all virtual recruitment in late 2020. Eligible individuals received a latter explaining the study and were called one week later to provide further details and determine interest.

Pre-assignment details

All enrolled participant completed a baseline survey prior to randomization

Participants by arm

ArmCount
Standard Care - Patient
The research study procedures include: screening for eligibility and study interventions including questionnaires and follow up visits. * In-person interview where the patient and caregiver together will randomized to either the video aid intervention or standard care * Receive the verbal description of the three types of care * Follow telephone interview at 3 months Usual Care: Verbal description of the three types of care
26
Standard Care - Caregiver
The research study procedures include: screening for eligibility and study interventions including questionnaires and follow up visits. * In-person interview where the patient and caregiver together will randomized to either the video aid intervention or standard care * Receive the verbal description of the three types of care * Follow telephone interview at 3 months Usual Care: Verbal description of the three types of care
26
ACP Video Decision Aid - Patient
The research study procedures include: screening for eligibility and study interventions including questionnaires and follow up visits. * In-person interview where the patient and caregiver together will randomized to either the video aid intervention or standard care * 10 minute video decision aid: describing the goals-of-care options . * Follow telephone interview at 3 months ACP video decision aid: 10 minute video decision aid describing the goals-of-care options
24
ACP Video Decision Aid - Caregiver
The research study procedures include: screening for eligibility and study interventions including questionnaires and follow up visits. * In-person interview where the patient and caregiver together will randomized to either the video aid intervention or standard care * 10 minute video decision aid: describing the goals-of-care options . * Follow telephone interview at 3 months ACP video decision aid: 10 minute video decision aid describing the goals-of-care options
24
Total100

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Three Month Follow-upDeath2000
Three Month Follow-upLost to Follow-up1455
Three Month Follow-upNot completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study1001
Three Month Follow-upWithdrawal by Subject1000

Baseline characteristics

CharacteristicStandard Care - PatientTotalACP Video Decision Aid - CaregiverACP Video Decision Aid - PatientStandard Care - Caregiver
Age, Continuous33.5 years
STANDARD_DEVIATION 6.1
37.6 years
STANDARD_DEVIATION 11.5
43.0 years
STANDARD_DEVIATION 13.8
32.7 years
STANDARD_DEVIATION 5.6
41.3 years
STANDARD_DEVIATION 13.6
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants2 Participants0 Participants0 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
24 Participants93 Participants23 Participants22 Participants24 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants5 Participants1 Participants2 Participants1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
3 Participants6 Participants1 Participants0 Participants2 Participants
Race (NIH/OMB)
Black or African American
1 Participants1 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants4 Participants2 Participants2 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants5 Participants1 Participants1 Participants2 Participants
Race (NIH/OMB)
White
21 Participants84 Participants20 Participants21 Participants22 Participants
Region of Enrollment
United States
26 participants100 participants24 participants24 participants26 participants
Sex: Female, Male
Female
16 Participants58 Participants14 Participants14 Participants14 Participants
Sex: Female, Male
Male
10 Participants42 Participants10 Participants10 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 252 / 250 / 25
other
Total, other adverse events
0 / 250 / 250 / 250 / 25
serious
Total, serious adverse events
0 / 250 / 250 / 250 / 25

Outcome results

Primary

Increased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)

AYA with advanced cancer and caregivers randomized to the video will have higher concordance in their stated goals of care between patients and caregivers at 3 month compared to baseline

Time frame: baseline, 3 months

Population: Analyzed as dyad. If one individual of the dyad did not complete study procedures, those results were not analyzed. One AYA assigned to standard care did not have a caregiver that was able to participate. One AYA of a caregiver assigned to video decision aid was unable to participate. As the unit of measurement was the DYAD, these two individuals (one standard arm, one video) were not analyzed although they did complete enrollment and baseline and follow-up assessments (but not 3 month)

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
ACP Video Decision AidIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care pre interventionNumber of dyads with concordant goals of care20 Participants
ACP Video Decision AidIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care pre interventionNumber of dyads with disconcordant goals of care5 Participants
ACP Video Decision AidIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care post interventionNumber of dyads with concordant goals of care13 Participants
ACP Video Decision AidIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care post interventionNumber of dyads with disconcordant goals of care12 Participants
ACP Video Decision AidIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care 3 months post interventionNumber of dyads with concordant goals of care10 Participants
ACP Video Decision AidIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care 3 months post interventionNumber of dyads with disconcordant goals of care15 Participants
Standard CareIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care 3 months post interventionNumber of dyads with concordant goals of care9 Participants
Standard CareIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care pre interventionNumber of dyads with concordant goals of care15 Participants
Standard CareIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care post interventionNumber of dyads with disconcordant goals of care10 Participants
Standard CareIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care pre interventionNumber of dyads with disconcordant goals of care10 Participants
Standard CareIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care 3 months post interventionNumber of dyads with disconcordant goals of care16 Participants
Standard CareIncreased Concordance Rate in Stated Goals of Care (Life-prolonging Medical Care, Selective Medical Care, or Comfort-focused Care)Concordance in goals of care post interventionNumber of dyads with concordant goals of care15 Participants
Secondary

Increased Advance Care Planning (ACP) Conversations

Patients randomized to the video will have more ACP conversations and documentation after 3 months.

Time frame: Baseline and 3 months

Population: AYA participants that had data at 3-month follow-up

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ACP Video Decision AidIncreased Advance Care Planning (ACP) ConversationsChange in number of AYAs that engaged in ACP conversations following the intervention to 3-months13 Participants
ACP Video Decision AidIncreased Advance Care Planning (ACP) ConversationsChange in number of AYAs that had ACP documentation from baseline to 3 months2 Participants
Standard CareIncreased Advance Care Planning (ACP) ConversationsChange in number of AYAs that engaged in ACP conversations following the intervention to 3-months13 Participants
Standard CareIncreased Advance Care Planning (ACP) ConversationsChange in number of AYAs that had ACP documentation from baseline to 3 months4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026